ArticleThe New England journal of medicine2023

Anti-Insulin Receptor Antibody for Malignant Insulinoma and Refractory Hypoglycemia.

Soravis Osataphan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.